Business Context and Reporting Period
Company: MiMedx Group, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 29, 2008
Reporting Period: Events occurring on April 29, 2008.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial statements. The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- Board Election: The Board of Directors elected Ronald G. Wallace as a director, effective immediately.
- Committee Assignments: Mr. Wallace will serve on the Audit and Compensation Committees.
- Code of Ethics: The Board adopted a new Code of Business Conduct and Ethics covering all directors, executive officers, and employees.
Guidance, Outlook, and Management Commentary
Director Background: Mr. Wallace is the former President of UPS International, a company with over $90 billion in revenue and 400,000 employees. He has extensive experience in global operations and board governance.
Compensation Structure:
- Annual retainer: $20,000 (payable quarterly).
- Meeting fees: $2,500 per in-person meeting; $500 per telephonic meeting.
- Committee fees: $5,000 annually for committee chairs; $2,500 annually for committee members.
- Equity grant: One-time stock option grant of 50,000 shares of Common Stock upon appointment.
Risks and Contingencies: No specific risks or contingencies were disclosed in this filing.
Important Facts for Investors to Verify
- Confirmation of Ronald G. Wallace's tenure on the Board and specific committee roles.
- Details of the newly adopted Code of Business Conduct and Ethics (Exhibit 14.1).
- Impact of the new director's background on the company's strategic direction.
- Verification of the stock option grant terms for the new director.